Please sign in to download the files. A new tab will open where you can login/register.


Brominated Fragment Library

Crystallographic fragment-based drug discovery (FBDD) has been gaining high importance in modern pharmaceutical technology. Fragments, however, are poor binders, with their partial occupancy resulting in weak, difficult-to-fit electron density. The use of bromine-containing fragments and X-ray crystallography can address this challenge, as bromine can be located uniquely via anomalous scattering, and thus, provide further insight into the nature of the target surface pocket [1].

The Life Chemicals Brominated Fragment Library consists of more than 2,700 drug-like compounds with MW ≤ 350 and ClogP ≤ 3.5 selected from the Life Chemicals HTS Compound Collection and General Fragment Library. All the bromine-substituted fragments contain only one Br-atom. Other important parameters (such as HBA, HBD, Fsp3, RotB, TPSA) are included in the data file and can be used for selection with multiple restrictions.

In addition, we have designed a Diversity Screening Set of 960 structurally-diverse bromine-labeled fragments to provide the most-promising drug-like screening compounds in a convenient manner. These brominated fragment-like molecules possess a wide range of chemical structure dissimilarity and are compliant with in-house MedChem and PAINS structural filters [6-7].

The compound selection can be customized based on your requirements, cherry picking is available.

Please, contact us at for any additional information and price quotations.

Representative bromine-containing fragments from the Screening Library


  1. Tiefenbrunn T. et al. Chem Biol Drug Des. 2014, 83, 141–148
  2. Peng H et al. Environ Sci Technol. 2016 Dec 6;50(23):12669-12677.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used. By using our website, you accept our conditions of use of cookies to track data and create content (including advertising) based on your interest. Accept